United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united kingdom - 60's [4x15's blister] - capsule - combination - nutrition , blood-oral nutrition

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united kingdom - 16 sachets - powder - combination - nutrition , blood-oral nutrition, nutrition , blood-vitamins

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united kingdom - 60's [4x15's blister] - capsule - combination - nutrition , blood-oral nutrition, nutrition , blood-vitamins

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united kingdom - 45's [3x15's blister] - capsule - combination - nutrition , blood-oral nutrition, nutrition , blood-vitamins

United States - English - NLM (National Library of Medicine)

bio products laboratory limited - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 5 g in 50 ml - gammaplex 10% is an immune globulin intravenous (human), 10% liquid indicated for replacement therapy in primary humoral immunodeficiency (pi) in adults and pediatric patients 2 years of age and older. this includes, but is not limited to, the humoral immune defect in common variable immunodeficiency, x-linked agammaglobulinemia, congenital agammaglobulinemia, wiskott-aldrich syndrome, and severe combined immunodeficiencies. gammaplex 10% is indicated for the treatment of chronic immune thrombocytopenic purpura (itp) in adults to raise platelet counts. - gammaplex 10% is contraindicated in patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin - gammaplex 10% is contraindicated in iga-deficient patients with antibodies to iga and a history of hypersensitivity risk summary animal reproduction studies have not been conducted with gammaplex 10%. it is also not known whether gammaplex 10% can cause fetal harm when administered to a pregnant woman or can af

United States - English - NLM (National Library of Medicine)

bio products laboratory limited - coagulation factor x human (unii: 0p94uqe6sy) (coagulation factor x human - unii:0p94uqe6sy) - coagulation factor x human 100 [iu] in 1 ml - coagadex, coagulation factor x (human), is a plasma-derived human blood coagulation factor indicated in adults and children with hereditary factor x deficiency for: - routine prophylaxis to reduce the frequency of bleeding episodes - on-demand treatment and control of bleeding episodes - perioperative management of bleeding in patients with mild, moderate, and severe hereditary factor x deficiency coagadex is contraindicated in patients who have had life-threatening hypersensitivity reactions to coagadex [see description (11) ]. risk summary there is limited data with coagadex in pregnant women to inform on drug-associated risk. animal reproduction studies have not been conducted using coagadex. it is not known whether coagadex can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. risk summary ther

United States - English - NLM (National Library of Medicine)

bio products laboratory limited - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - gammaplex 5% is an immune globulin intravenous (human), 5% liquid indicated for replacement therapy in primary humoral immunodeficiency (pi) in adults and pediatric patients 2 years of age and older. this includes, but is not limited to, the humoral immune defect in common variable immunodeficiency, x-linked agammaglobulinemia (xla), congenital agammaglobulinemia, wiskott-aldrich syndrome, and severe combined immunodeficiencies. gammaplex 5% is indicated for the treatment of chronic immune thrombocytopenic purpura (itp) to raise platelet counts. - gammaplex 5% is contraindicated in patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. - gammaplex 5% is contraindicated in patients with hereditary intolerance to fructose, also in infants and neonates for whom sucrose or fructose tolerance has not been established. - gammaplex 5% is contraindicated in iga-deficient patients with antibodies to iga and a history of hypersensitivity. risk summary a

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmazone medical equipments united kingdom - 3's[3x1's blister] - device - combination - eye-contact lenses

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

medicals international united kingdom - 6 contact lenses - device - combination - eye-contact lenses

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

medicals international united kingdom - 6 contact lenses - device - combination - eye-contact lenses